Detailed price information for Agios Pharmaceuticals (AGIO-Q) from The Globe and Mail including charting and trades.

SAN DIEGO--(BUSINESS WIRE)-- Travere Therapeutics, Inc. (TVTX) today reported its first quarter 2025 financial results and provided a corporate update. Net product sales for the first quarter of ...

SAN DIEGO--(BUSINESS WIRE)--#1Q25earnings--Travere Therapeutics, Inc. (NASDAQ: TVTX) today reported its first quarter 2025 financial results and provided a corporate update. “As the only fully ...

Background: Pharmacogenomic (PGx) variants can significantly impact drug response, but limited data exists on their prevalence in Middle Eastern populations. This study aimed to investigate the ...

The UK’s MHRA also converts the conditional approval of FILSPARI to standard approval Travere Therapeutics, Inc., (NASDAQ: TVTX) and CSL Vifor are pleased to announce that the European ...

SAN DIEGO & ST. GALLEN, Switzerland--(BUSINESS WIRE)--$TVTX--Travere Therapeutics, Inc., (NASDAQ: TVTX) and CSL Vifor are pleased to announce that the European ...